MethylGene Inc MYLGF

Facts only facts

[pepman]

Yes, with Methylgene's management you get the facts straight. You will never read in a press release that there was an expression of interest from an unknown pharma for a takeover. They will not publish a press release about a letter of intent for a partnership. Possible takeover talks will remain private, and they will publish a press release only when a real deal is signed. No lobster trap. No gimmick. Just the real facts. Be sure that if a good news come, you won't see the stock rise in the weeks or days before it. Everybody outside the company will be informed at the same time.

So yes, they are lower and lower on money. This is a concern. This is a risk factor. And this is a fact. But be sure there will not be a news about a strategic review that will end up in a tax losses deal. No. This company needs to be analyzed about the potential of it's drug candidates. Not about it's remaining cash. If the candidates are worthy of somenthing, news will come in a timely manner. So there will be no pumping here. No rosy scenarios based on partnership dreams and takeover fantasies. Just the facts. And because this company is only publishing facts. The last 18 months were very hard for Methylgene. There was nothing to be happy with. But they stick to the basics, They did what they had to do, and the next six months are going to be critical. Turnaround is near, but this only my opinion based on the science behind the candidates. But biotech is a risky business. No lobster thinking here.